Clinical trials
Diabetic Nephropathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
151 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 10 |
| 2010 | 8 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 13 |
| 2022 | 11 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 94 |
| Terminated | 18 |
| Recruiting | 17 |
| Active, not recruiting | 11 |
| Not yet recruiting | 3 |
| Withdrawn | 3 |
| Suspended | 2 |
| Enrolling by invitation | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Colorado, Denver | 11 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 10 |
| AstraZeneca | 4 |
| Goldfinch Bio, Inc. | 4 |
| Renalytix AI, Inc. | 4 |
| University of Washington | 4 |
| AbbVie (prior sponsor, Abbott) | 3 |
| Alessandro Doria | 3 |
| Bayer | 3 |
| Biogen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 151 |
| Diabetes Mellitus, Type 2 | 40 |
| Renal Insufficiency, Chronic | 38 |
| Diabetes Mellitus | 35 |
| Kidney Diseases | 24 |
| Diabetes Mellitus, Type 1 | 16 |
| Proteinuria | 15 |
| Diabetes Complications | 13 |
| Albuminuria | 12 |
| Glomerulosclerosis, Focal Segmental | 6 |
Trials
Showing 1 to 25 of 151. Each trial links to its page on Pharma Observatory.
51 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.